Home LiteratureArticle Details
PMID: 17079235 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits.

The Journal of biological chemistry ·Vol. 281 ·No. 50 ·2006-12-15 ·Pages 38122-6

Wedekind JE, Gillilan R, Janda A, Krucinska J, Salter JD, Bennett RP, Raina J, Smith HC

Abstract

Human APOBEC3G (hA3G) is a cytidine deaminase that restricts human immunodeficiency virus (HIV)-1 infection in a vif (the virion infectivity factor from HIV)-dependent manner. hA3G from HIV-permissive activated CD4+ T-cells exists as an inactive, high molecular mass (HMM) complex that can be transformed in vitro into an active, low molecular mass (LMM) variant comparable with that of HIV-non-permissive CD4+ T-cells. Here we present low resolution structures of hA3G in HMM and LMM forms determined by small angle x-ray scattering and advanced shape reconstruction methods. The results show that LMM particles have an extended shape, dissimilar to known cytidine deaminases, featuring novel tail-to-tail dimerization. Shape analysis of LMM and HMM structures revealed how symmetric association of dimers could lead to minimal HMM variants. These observations imply that the disruption of cellular HMM particles may require regulation of protein-RNA, as well as protein-protein interactions, which has implications for therapeutic development.

MeSH Terms
APOBEC-3G Deaminase CD4-Positive T-Lymphocytes/metabolism Cell Line Cytidine Deaminase Dimerization Humans Molecular Weight Nanostructures Nucleoside Deaminases/chemistry,metabolism Repressor Proteins/chemistry,metabolism Scattering, Radiation
Chemicals
Repressor Proteins Nucleoside Deaminases APOBEC-3G Deaminase APOBEC3G protein, human Cytidine Deaminase
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Wedekind Joseph E
Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA. joseph_wedekind@urms.rochester.edu
Gillilan Richard
Janda Alena
Krucinska Jolanta
Salter Jason D
Bennett Ryan P
Raina Jay
Smith Harold C
References (32)
32 references, click to expand
  1. Modeling tricks and fitting techniques for multiresolution structures.
    Structure. 2001 Sep;9(9):779-88 PMID: 11566128
  2. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules.
    J Biol Chem. 2006 Sep 29;281(39):29105-19 PMID: 16887808
  3. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.
    Genomics. 2002 Mar;79(3):285-96 PMID: 11863358
  4. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
    J Cell Sci. 2002 Mar 1;115(Pt 5):1027-39 PMID: 11870221
  5. Multi-resolution contour-based fitting of macromolecular structures.
    J Mol Biol. 2002 Mar 29;317(3):375-84 PMID: 11922671
  6. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
    Nature. 2002 Aug 8;418(6898):646-50 PMID: 12167863
  7. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business.
    Trends Genet. 2003 Apr;19(4):207-16 PMID: 12683974
  8. Hypermutation of HIV-1 DNA in the absence of the Vif protein.
    Science. 2003 May 16;300(5622):1112 PMID: 12750511
  9. DNA deamination mediates innate immunity to retroviral infection.
    Cell. 2003 Jun 13;113(6):803-9 PMID: 12809610
  10. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.
    Nature. 2003 Jul 3;424(6944):94-8 PMID: 12808465
  11. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Nature. 2003 Jul 3;424(6944):99-103 PMID: 12808466
  12. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.
    Cell. 2003 Jul 11;114(1):21-31 PMID: 12859895
  13. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.
    Mol Cell. 2003 Sep;12(3):591-601 PMID: 14527406
  14. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.
    Nat Struct Mol Biol. 2004 May;11(5):435-42 PMID: 15098018
  15. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.
    Proc Natl Acad Sci U S A. 2004 May 25;101(21):8114-9 PMID: 15148397
  16. Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex.
    J Mol Biol. 1994 Jan 14;235(2):635-56 PMID: 8289286
  17. Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition.
    J Mol Biol. 1998 Jan 30;275(4):695-714 PMID: 9466941
  18. Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing.
    Biophys J. 1999 Jun;76(6):2879-86 PMID: 10354416
  19. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.
    Curr Biol. 2005 Jan 26;15(2):166-70 PMID: 15668174
  20. Structure of human cytidine deaminase bound to a potent inhibitor.
    J Med Chem. 2005 Feb 10;48(3):658-60 PMID: 15689149
  21. Complementary function of the two catalytic domains of APOBEC3G.
    Virology. 2005 Mar 15;333(2):374-86 PMID: 15721369
  22. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins.
    Virology. 2005 Apr 10;334(2):147-53 PMID: 15780864
  23. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
    Nature. 2005 May 5;435(7038):108-14 PMID: 15829920
  24. Structural basis of cellulosome efficiency explored by small angle X-ray scattering.
    J Biol Chem. 2005 Nov 18;280(46):38562-8 PMID: 16157599
  25. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation.
    J Exp Med. 2006 Apr 17;203(4):865-70 PMID: 16606671
  26. Monomeric APOBEC3G is catalytically active and has antiviral activity.
    J Virol. 2006 May;80(10):4673-82 PMID: 16641260
  27. Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.
    J Virol. 2006 Jun;80(12):5992-6002 PMID: 16731938
  28. APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.
    Nat Struct Mol Biol. 2006 May;13(5):392-9 PMID: 16622407
  29. Conformation of polypyrimidine tract binding protein in solution.
    Structure. 2006 Jun;14(6):1021-7 PMID: 16765895
  30. Modular structure of solubilized human apolipoprotein B-100. Low resolution model revealed by small angle neutron scattering.
    J Biol Chem. 2006 Jul 14;281(28):19732-9 PMID: 16704977
  31. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
    J Virol. 2006 Aug;80(15):7645-57 PMID: 16840343
  32. Crystal structure of the tetrameric cytidine deaminase from Bacillus subtilis at 2.0 A resolution.
    Biochemistry. 2002 Feb 26;41(8):2563-70 PMID: 11851403
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2006-12-15
Epub
2006-00-31
Pages
38122-6
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC1847398
Subset
IM
Grants
NCRR NIH HHS · RR 01646 · United States
NIAID NIH HHS · T32 AI049815 · United States
NCRR NIH HHS · P41 RR001646 · United States
NIAID NIH HHS · R21 AI058789 · United States
NIAID NIH HHS · T32 AI 49815 · United States
NIGMS NIH HHS · DMR0225180 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com